These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 8197600)
21. Induction of indefinite survival of fully allogeneic cardiac grafts and generation of regulatory cells by intratracheal delivery of alloantigens under blockade of the CD40 pathway. Uchida N; Shirasugi N; Akiyama Y; Matsumoto K; Shimazu M; Kitajima M; Hamano K; Aramaki O; Ikeda Y; Niimi M Transplantation; 2003 Mar; 75(6):878-84. PubMed ID: 12660518 [TBL] [Abstract][Full Text] [Related]
22. Prolonged survival of fetal pig islet xenografts in mice lacking the capacity for an indirect response. Koulmanda M; Laufer TM; Auchincloss H; Smith RN Xenotransplantation; 2004 Nov; 11(6):525-30. PubMed ID: 15479462 [TBL] [Abstract][Full Text] [Related]
23. Lymphocyte changes associated with prolongation of cardiac allograft survival in adult mice using anti-CD4 monoclonal antibody. Pearson TC; Bushell AR; Darby CR; West LJ; Morris PJ; Wood KJ Clin Exp Immunol; 1993 May; 92(2):211-7. PubMed ID: 8097975 [TBL] [Abstract][Full Text] [Related]
24. Prolonged local expression of anti-CD4 antibody by adenovirally transduced allografts can promote long-term graft survival. Londrigan SL; Sutherland RM; Brady JL; Zhan Y; Li R; Estella E; Kay TW; Lew AM J Gene Med; 2006 Jan; 8(1):42-52. PubMed ID: 16075436 [TBL] [Abstract][Full Text] [Related]
25. Nondepleting anti-CD4 monoclonal antibody enhances the ability of oral alloantigen delivery to induce indefinite survival of cardiac allografts: oral tolerance to alloantigen. Niimi M; Witzke O; Bushell A; Hara M; Morris PJ; Wood KJ Transplantation; 2000 Nov; 70(10):1524-8. PubMed ID: 11118100 [TBL] [Abstract][Full Text] [Related]
26. Effect of anti-CD4, anti-NC, and anti-NK monoclonal antibody on the survival of cardiac xenografts and allografts in mice. Yang L; Mottram PL; Han WR; Smart YC Transplant Proc; 1995 Jun; 27(3):2185-6. PubMed ID: 7792927 [No Abstract] [Full Text] [Related]
27. Current and future application of monoclonal antibodies in clinical immunosuppressive protocols. Cosimi AB Clin Transplant; 1995 Jun; 9(3 Pt 2):219-26. PubMed ID: 7670167 [No Abstract] [Full Text] [Related]
28. AMIS and antigen modulation: of mice and men. Westhoff CM Blood; 2016 Dec; 128(26):3026-3028. PubMed ID: 28034869 [No Abstract] [Full Text] [Related]
29. Cool response to report on YTS placements. McNally M Nurs Stand; 1988 Jan; 2(14):14. PubMed ID: 27414550 [TBL] [Abstract][Full Text] [Related]
31. A brief spiritual beliefs inventory for use in quality of life research in life-threatening illness. Holland JC; Kash KM; Passik S; Gronert MK; Sison A; Lederberg M; Russak SM; Baider L; Fox B Psychooncology; 1998; 7(6):460-9. PubMed ID: 9885087 [TBL] [Abstract][Full Text] [Related]
32. Differential response of human melanoma and Ehrlich ascites cells in vitro to the ribosome-inactivating protein luffin. Poma A; Miranda M; Spanò L Melanoma Res; 1998 Oct; 8(5):465-7. PubMed ID: 9835461 [TBL] [Abstract][Full Text] [Related]
33. [Clear cell sarcoma of soft tissues. Clinico-pathological and ultrastructural analysis of a case in the head-neck region and a literature review]. Bisceglia M; Carosi I; Lelli G; Pasquinelli G; Martinelli GN Pathologica; 1998 Aug; 90(4):391-6. PubMed ID: 9793401 [TBL] [Abstract][Full Text] [Related]